Lotus Pharmaceuticals Stock Buy Hold or Sell Recommendation
| LTUS Stock | USD 0.01 0 28.57% |
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Lotus Pharmaceuticals is 'Not Rated'. Macroaxis provides Lotus Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding LTUS positions. The advice algorithm takes into account all of Lotus Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Lotus Pharmaceuticals' buy or sell advice are summarized below:
Real Value 0.0 | Hype Value 0.0 | Market Value 0.005 | Naive Value 0.003922 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Lotus Pharmaceuticals given historical horizon and risk tolerance towards Lotus Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Lotus Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Lotus |
Execute Lotus Pharmaceuticals Buy or Sell Advice
The Lotus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Lotus Pharmaceuticals. Macroaxis does not own or have any residual interests in Lotus Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Lotus Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Lotus Pharmaceuticals Trading Alerts and Improvement Suggestions
| Lotus Pharmaceuticals is way too risky over 90 days horizon | |
| Lotus Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Lotus Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| The company currently holds 5.24 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. Lotus Pharmaceuticals has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Lotus Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Lotus Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Lotus Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Lotus to invest in growth at high rates of return. When we think about Lotus Pharmaceuticals' use of debt, we should always consider it together with cash and equity. |
Lotus Pharmaceuticals Returns Distribution Density
The distribution of Lotus Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Lotus Pharmaceuticals' future price movements. The chart of the probability distribution of Lotus Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Lotus Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Lotus Pharmaceuticals returns is essential to provide solid investment advice for Lotus Pharmaceuticals.
| Mean Return | 1.31 | Value At Risk | -11.43 | Potential Upside | 27.91 | Standard Deviation | 15.32 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Lotus Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Lotus Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Lotus Pharmaceuticals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Lotus Pharmaceuticals' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Lotus pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 1.77 | |
β | Beta against NYSE Composite | -6.37 | |
σ | Overall volatility | 15.32 | |
Ir | Information ratio | 0.08 |
Lotus Pharmaceuticals Volatility Alert
Lotus Pharmaceuticals is showing large volatility of returns over the selected time horizon. Lotus Pharmaceuticals is a penny stock. Even though Lotus Pharmaceuticals may be a good instrument to invest, many penny pink sheets are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Lotus Pharmaceuticals or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Lotus instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Lotus Pharmaceuticals Fundamentals Vs Peers
Comparing Lotus Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Lotus Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Lotus Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Lotus Pharmaceuticals or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Lotus Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Lotus Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Lotus Pharmaceuticals to competition |
| Fundamentals | Lotus Pharmaceuticals | Peer Average |
| Return On Equity | 0.0182 | -0.31 |
| Return On Asset | 0.0456 | -0.14 |
| Profit Margin | 0.02 % | (1.27) % |
| Operating Margin | 0.11 % | (5.51) % |
| Current Valuation | 762.17 K | 16.62 B |
| Shares Outstanding | 27.82 M | 571.82 M |
| Price To Earning | 0.18 X | 28.72 X |
| Price To Book | 0.01 X | 9.51 X |
| Price To Sales | 0.01 X | 11.42 X |
| Revenue | 72.7 M | 9.43 B |
| Gross Profit | 39.78 M | 27.38 B |
| EBITDA | 10.31 M | 3.9 B |
| Net Income | 14.42 M | 570.98 M |
| Cash And Equivalents | 158.91 K | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Total Debt | 5.24 M | 5.32 B |
| Debt To Equity | 0.06 % | 48.70 % |
| Current Ratio | 0.53 X | 2.16 X |
| Book Value Per Share | 3.58 X | 1.93 K |
| Cash Flow From Operations | 26.78 M | 971.22 M |
| Earnings Per Share | 0.06 X | 3.12 X |
| Number Of Employees | 233 | 18.84 K |
| Beta | 0.51 | -0.15 |
| Market Capitalization | 834.49 K | 19.03 B |
| Total Asset | 103.18 M | 29.47 B |
| Retained Earnings | 65 M | 9.33 B |
| Working Capital | (6 M) | 1.48 B |
| Current Asset | 8 M | 9.34 B |
| Current Liabilities | 14 M | 7.9 B |
| Net Asset | 103.18 M |
Lotus Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Lotus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.71 | |||
| Day Median Price | 0.005 | |||
| Day Typical Price | 0.005 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0) | |||
| Relative Strength Index | 47.48 |
About Lotus Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Lotus Pharmaceuticals? Buying financial instruments such as Lotus Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Lotus Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Driverless Cars Thematic Idea Now
Driverless Cars
It encompasses large technology companies, automotive makers, security firms, and thematic ETFs across multiple industries. These entities are directly or indirectly involved in shaping the development and marketing of self-driving vehicles. The Driverless Cars theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Driverless Cars Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Lotus Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Lotus Pink Sheet analysis
When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |